Therapeutic inhibition of keratinocyte TRPV3 sensory channel by local anesthetic dyclonine

The multimodal sensory channel transient receptor potential vanilloid-3 (TRPV3) is expressed in epidermal keratinocytes and implicated in chronic pruritus, allergy, and inflammation-related skin disorders. Gain-of-function mutations of TRPV3 cause hair growth disorders in mice and Olmsted syndrome i...

Full description

Bibliographic Details
Main Authors: Qiang Liu, Jin Wang, Xin Wei, Juan Hu, Conghui Ping, Yue Gao, Chang Xie, Peiyu Wang, Peng Cao, Zhengyu Cao, Ye Yu, Dongdong Li, Jing Yao
Format: Article
Language:English
Published: eLife Sciences Publications Ltd 2021-04-01
Series:eLife
Subjects:
Online Access:https://elifesciences.org/articles/68128
_version_ 1818019099585806336
author Qiang Liu
Jin Wang
Xin Wei
Juan Hu
Conghui Ping
Yue Gao
Chang Xie
Peiyu Wang
Peng Cao
Zhengyu Cao
Ye Yu
Dongdong Li
Jing Yao
author_facet Qiang Liu
Jin Wang
Xin Wei
Juan Hu
Conghui Ping
Yue Gao
Chang Xie
Peiyu Wang
Peng Cao
Zhengyu Cao
Ye Yu
Dongdong Li
Jing Yao
author_sort Qiang Liu
collection DOAJ
description The multimodal sensory channel transient receptor potential vanilloid-3 (TRPV3) is expressed in epidermal keratinocytes and implicated in chronic pruritus, allergy, and inflammation-related skin disorders. Gain-of-function mutations of TRPV3 cause hair growth disorders in mice and Olmsted syndrome in humans. Nevertheless, whether and how TRPV3 could be therapeutically targeted remains to be elucidated. We here report that mouse and human TRPV3 channel is targeted by the clinical medication dyclonine that exerts a potent inhibitory effect. Accordingly, dyclonine rescued cell death caused by gain-of-function TRPV3 mutations and suppressed pruritus symptoms in vivo in mouse model. At the single-channel level, dyclonine inhibited TRPV3 open probability but not the unitary conductance. By molecular simulations and mutagenesis, we further uncovered key residues in TRPV3 pore region that could toggle the inhibitory efficiency of dyclonine. The functional and mechanistic insights obtained on dyclonine-TRPV3 interaction will help to conceive therapeutics for skin inflammation.
first_indexed 2024-04-14T07:47:47Z
format Article
id doaj.art-4762a5c2c8eb48cfa6f33ecd4d878ac0
institution Directory Open Access Journal
issn 2050-084X
language English
last_indexed 2024-04-14T07:47:47Z
publishDate 2021-04-01
publisher eLife Sciences Publications Ltd
record_format Article
series eLife
spelling doaj.art-4762a5c2c8eb48cfa6f33ecd4d878ac02022-12-22T02:05:17ZengeLife Sciences Publications LtdeLife2050-084X2021-04-011010.7554/eLife.68128Therapeutic inhibition of keratinocyte TRPV3 sensory channel by local anesthetic dyclonineQiang Liu0Jin Wang1Xin Wei2Juan Hu3Conghui Ping4Yue Gao5Chang Xie6Peiyu Wang7Peng Cao8Zhengyu Cao9Ye Yu10Dongdong Li11https://orcid.org/0000-0002-6731-4771Jing Yao12https://orcid.org/0000-0003-1844-3988State Key Laboratory of Virology, Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, ChinaSchool of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, ChinaState Key Laboratory of Virology, Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, ChinaState Key Laboratory of Virology, Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, ChinaState Key Laboratory of Virology, Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, ChinaState Key Laboratory of Virology, Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, ChinaState Key Laboratory of Virology, Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, ChinaState Key Laboratory of Virology, Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, ChinaHospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, ChinaState Key Laboratory of Natural Medicines and Jiangsu Provincial Key Laboratory for TCM Evaluation and Translational Development, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, ChinaSchool of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, ChinaSorbonne Université, Institute of Biology Paris Seine, Neuroscience Paris Seine, CNRS UMR8246, Inserm U1130, Paris, FranceState Key Laboratory of Virology, Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, ChinaThe multimodal sensory channel transient receptor potential vanilloid-3 (TRPV3) is expressed in epidermal keratinocytes and implicated in chronic pruritus, allergy, and inflammation-related skin disorders. Gain-of-function mutations of TRPV3 cause hair growth disorders in mice and Olmsted syndrome in humans. Nevertheless, whether and how TRPV3 could be therapeutically targeted remains to be elucidated. We here report that mouse and human TRPV3 channel is targeted by the clinical medication dyclonine that exerts a potent inhibitory effect. Accordingly, dyclonine rescued cell death caused by gain-of-function TRPV3 mutations and suppressed pruritus symptoms in vivo in mouse model. At the single-channel level, dyclonine inhibited TRPV3 open probability but not the unitary conductance. By molecular simulations and mutagenesis, we further uncovered key residues in TRPV3 pore region that could toggle the inhibitory efficiency of dyclonine. The functional and mechanistic insights obtained on dyclonine-TRPV3 interaction will help to conceive therapeutics for skin inflammation.https://elifesciences.org/articles/68128TRPV3dycloninecell deathpruritusskin inflammation
spellingShingle Qiang Liu
Jin Wang
Xin Wei
Juan Hu
Conghui Ping
Yue Gao
Chang Xie
Peiyu Wang
Peng Cao
Zhengyu Cao
Ye Yu
Dongdong Li
Jing Yao
Therapeutic inhibition of keratinocyte TRPV3 sensory channel by local anesthetic dyclonine
eLife
TRPV3
dyclonine
cell death
pruritus
skin inflammation
title Therapeutic inhibition of keratinocyte TRPV3 sensory channel by local anesthetic dyclonine
title_full Therapeutic inhibition of keratinocyte TRPV3 sensory channel by local anesthetic dyclonine
title_fullStr Therapeutic inhibition of keratinocyte TRPV3 sensory channel by local anesthetic dyclonine
title_full_unstemmed Therapeutic inhibition of keratinocyte TRPV3 sensory channel by local anesthetic dyclonine
title_short Therapeutic inhibition of keratinocyte TRPV3 sensory channel by local anesthetic dyclonine
title_sort therapeutic inhibition of keratinocyte trpv3 sensory channel by local anesthetic dyclonine
topic TRPV3
dyclonine
cell death
pruritus
skin inflammation
url https://elifesciences.org/articles/68128
work_keys_str_mv AT qiangliu therapeuticinhibitionofkeratinocytetrpv3sensorychannelbylocalanestheticdyclonine
AT jinwang therapeuticinhibitionofkeratinocytetrpv3sensorychannelbylocalanestheticdyclonine
AT xinwei therapeuticinhibitionofkeratinocytetrpv3sensorychannelbylocalanestheticdyclonine
AT juanhu therapeuticinhibitionofkeratinocytetrpv3sensorychannelbylocalanestheticdyclonine
AT conghuiping therapeuticinhibitionofkeratinocytetrpv3sensorychannelbylocalanestheticdyclonine
AT yuegao therapeuticinhibitionofkeratinocytetrpv3sensorychannelbylocalanestheticdyclonine
AT changxie therapeuticinhibitionofkeratinocytetrpv3sensorychannelbylocalanestheticdyclonine
AT peiyuwang therapeuticinhibitionofkeratinocytetrpv3sensorychannelbylocalanestheticdyclonine
AT pengcao therapeuticinhibitionofkeratinocytetrpv3sensorychannelbylocalanestheticdyclonine
AT zhengyucao therapeuticinhibitionofkeratinocytetrpv3sensorychannelbylocalanestheticdyclonine
AT yeyu therapeuticinhibitionofkeratinocytetrpv3sensorychannelbylocalanestheticdyclonine
AT dongdongli therapeuticinhibitionofkeratinocytetrpv3sensorychannelbylocalanestheticdyclonine
AT jingyao therapeuticinhibitionofkeratinocytetrpv3sensorychannelbylocalanestheticdyclonine